SMASH standardised perioperative management of patients operated with acute abdominal surgery in a high-risk setting

• Published in: BMC research notes 2020-03, Vol.13 (1), p.193-193, Article 193
• Main Authors: Timan, Terje Jansson, Sernert, Ninni, Karlsson, Ove, Prytz, Mattias
• Format: Article
• Language: English
• Subjects: Abdomen; Abdominal; Abdominal surgery; Acute Disease; Anaesthesiology; Analytical chemistry; Antibiotics; Blood pressure; Clinical Medicine; Clinical Protocols - standards; Critically ill; Emergency; Emergency Service, Hospital - standards; Evaluation; Health Services Research; Hospitals; Hospitals, County - standards; Humans; Intensive care; Klinisk medicin; Laparotomy; Laparotomy - mortality; Laparotomy - standards; Management; Medical protocols; Methods; Morbidity; Mortality; Outcome and Process Assessment, Health Care - statistics & numerical data; Patients; Perioperative; Perioperative Care - standards; Postoperative Complications - epidemiology; Postoperative period; Research Note; Sepsis; Surgery; Sweden; Vital signs
• ISSN: 1756-0500; 1756-0500
• DOI: 10.1186/s13104-020-05030-4

Emergency laparotomy and other high-risk acute abdominal surgery procedures have a high mortality rate. The perioperative management of these patients is complex and poses several challenges. The objective of the study is to implement and evaluate the outcome of protocol-based standardised care for patients in need of acute abdominal surgery in a Swedish setting. NÄL is a large county hospital in Sweden serving a population of approximately 270,000 inhabitants. The study seeks to determine whether standardised protocol-based perioperative management in emergency abdominal surgical procedures leads to a better outcome measured as short- and long-term mortality and postoperative complications compared with the present standard in Swedish routine care. The study is ongoing, and this article describes the methodology used in the study and discusses the benefits and limitations the study design. There are no results so far. The inclusion rate for the first 22 months is as expected; 404 patients have been included and protocols have been followed and reviewed according to the study plan. 25 patients have been missed and demographic data and outcome data for these patients will be collected and analysed.